InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Shares Outstanding (2017 - 2026)

InflaRx (IFRX) posted Shares Outstanding (Entity) of $1.7 billion for Q4 2025, down 0.68% sequentially from $1.7 billion in Q2 2025, and up 14.2% YoY from $1.5 billion in Q4 2024.

InflaRx (IFRX) Shares Outstanding (2017 - 2026) Analysis & Trends

InflaRx has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $1.7 billion in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 14.2% year-over-year to $1.7 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 billion (up 14.2% YoY) and the FY2025 annual result came in at $1.7 billion, up 14.2% from the prior year.
  • Shares Outstanding (Entity) declined to $1.7 billion in Q4 2025 per IFRX's latest filing, from $1.7 billion in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $1.7 billion in Q2 2025 and troughed at $1.0 billion in Q4 2021.
  • A 5-year average of $1.4 billion and a median of $1.4 billion in 2023 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) declined 24.97% in 2022, then climbed 28.92% in 2023.
  • Over 5 years, Shares Outstanding (Entity) stood at $1.0 billion in 2021, then increased by 6.19% to $1.1 billion in 2022, then gained by 24.28% to $1.4 billion in 2023, then increased by 7.24% to $1.5 billion in 2024, then advanced by 14.2% to $1.7 billion in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.7 billion, $1.7 billion, and $1.5 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn 67.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 67.29 Mn
Dec 31, 2025 67.29 Mn
Sep 30, 2025 67.75 Mn
Jun 30, 2025 67.75 Mn
Mar 31, 2025 58.92 Mn
Dec 31, 2024 58.92 Mn
Sep 30, 2024 58.88 Mn
Jun 30, 2024 58.88 Mn
Mar 31, 2024 54.94 Mn
Dec 31, 2023 54.94 Mn
Sep 30, 2023 56.99 Mn
Jun 30, 2023 56.99 Mn
Mar 31, 2023 44.21 Mn
Dec 31, 2022 44.21 Mn
Sep 30, 2022 44.20 Mn
Jun 30, 2022 44.20 Mn
Mar 31, 2022 41.63 Mn
Dec 31, 2021 41.63 Mn
Sep 30, 2021 44.19 Mn
Jun 30, 2021 44.19 Mn